相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of adherence in virological suppression in patients receiving anti-HBV analogues
Philippe Sogni et al.
ANTIVIRAL THERAPY (2012)
Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B
Nghiem B. Ha et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma
Chuen-Fei Chen et al.
GASTROENTEROLOGY (2011)
Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
No Resistance to Tenofovir Disoproxil Fumarate Detected After up to 144 Weeks of Therapy in Patients Monoinfected With Chronic Hepatitis B Virus
Andrea Snow-Lampart et al.
HEPATOLOGY (2011)
Entecavir Treatment for Chronic Hepatitis B: Adaptation Is Not Needed for the Majority of Naive Patients with a Partial Virological Response
Roeland Zoutendijk et al.
HEPATOLOGY (2011)
Efficacy and Safety of Entecavir Versus Adefovir in Chronic Hepatitis B Patients With Hepatic Decompensation: A Randomized, Open-Label Study
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice
E. Ridruejo et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Natural history of chronic hepatitis B REVEALed
Chien-Jen Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
OUTCOME OF 4-YEAR TREATMENT OF ENTECAVIR FOR TREATMENT-NAIVE CHRONIC HEPATITIS B
W-K. Seto et al.
JOURNAL OF HEPATOLOGY (2011)
Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B
Stefan Mauss et al.
JOURNAL OF HEPATOLOGY (2011)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
1016 LOW RATES OF NUCLEOS(T)IDE-ASSOCIATED ADVERSE EVENTS IN THE LONG-TERM EXPERIENCE WITH ENTECAVIR
M. Manns et al.
JOURNAL OF HEPATOLOGY (2010)
Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis
Ju Hyun Shim et al.
JOURNAL OF HEPATOLOGY (2010)
Review: Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B
Andrés Duarte-Rojo et al.
Therapeutic Advances in Gastroenterology (2010)
Severe Lactic Acidosis During Treatment of Chronic Hepatitis B with Entecavir in Patients with Impaired Liver Function
Christian M. Lange et al.
HEPATOLOGY (2009)
Long-Term Monitoring Shows Hepatitis B Virus Resistance to Entecavir in Nucleoside-Naive Patients Is Rare Through 5 Years of Therapy
Daniel J. Tenney et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
ENTECAVIR MAINTAINS A HIGH GENETIC BARRIER TO HBV RESISTANCE THROUGH 6 YEARS IN NAIVE PATIENTS
D. J. Tenney et al.
JOURNAL OF HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2008)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Entecavir for treatment of hepatitis B virus displays no in vitro mitochondrial toxicity or DNA polymerase γ inhibition
Charles E. Mazzucco et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Entecavir therapy for up to 96 weeks in patients with HBeAg-Positive chronic hepatitis B
Robert G. Gish et al.
GASTROENTEROLOGY (2007)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature
H Mommeja-Marin et al.
HEPATOLOGY (2003)
分享论文
